Latest News

• share
• favorite_border

Findings could improve diagnostics and lead to new treatments

• share
• favorite_border

Mount Sinai Kravis Children’s Hospital announced today that PetSmart Charities has offered a gift of $75,000 to extend the tenure of Professor Bunsen Honeydew the hospital’s first of three facility dogs, through October 2020.

• share
• favorite_border

Findings may inform genetic screening test for patients at risk and medically under-served

• share
• favorite_border

Mone Zaidi, MD, PhD, Director of the Mount Sinai Bone Program, has been named a Fellow of the American Association for the Advancement of Science (AAAS)

• share
• favorite_border

Mount Sinai researchers have designed an innovative experimental therapy that may be able to stop the growth of triple-negative breast cancer, the deadliest type of breast cancer, which has few effective treatment options, according to a study published in Nature Chemical Biology in December.

• share
• favorite_border

The Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai has received a $1 million grant from The Arthur M. Blank Family Foundation.

• share
• favorite_border

A process called sporulation that helps the dangerous bacterium Clostridium difficile (C. difficile) to survive inhospitable conditions and spread is regulated by epigenetics, factors that affect gene expression beyond the DNA genetic code.

• share
• favorite_border

New Approach Will Lead to a Better Understanding of Most Cases

• share
• favorite_border

(New York, NY – November 19, 2019) Mount Sinai Kravis Children’s Hospital announced today that it has partnered with the Bezos Family Foundation and Vroom, the Foundation’s early learning program. Their shared purpose involves transforming the environment of six highly trafficked clinic spaces throughout the hospital into places for adults and children to have high-quality interactions that enhance early brain development during the critical years from birth to age five.

• share
• favorite_border

New “big omics” supercomputer will speed up solutions; insights will lead to advances in a wide range of complex diseases

• share
• favorite_border

Recent study found that an effective blood cancer treatment was associated with weight gain, obesity, and increased systolic blood pressure

• share
• favorite_border

Study Shows Vascular Ultrasounds and Adhering to Interventional Education in Underserved Communities can Improve Health among Parents and School Staff

• share
• favorite_border

Mount Sinai Medical-Legal Partnership (MSMLP), an organization formed to address the legal needs of Mount Sinai’s neediest patients, unveiled two initiatives that provide free special education law and advocacy assistance to families and patients in need. The announcement was made at an event held Wednesday at Mount Sinai that also honored the work of contributions of Blaine (“Fin”) Fogg, who was a member of the Boards of Trustees of the Mount Sinai Health System.

• share
• favorite_border

A study by researchers at Icahn School of Medicine at Mount Sinai proposes a novel method for identifying patterns in the frequency and cost of multiple chronic conditions (MCC).

• share
• favorite_border

The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.

• share
• favorite_border

A medical science tool for individuals to compare the effectiveness of wellness-related treatments

• share
• favorite_border

FastER Track will provide rapid access to care for low-acuity conditions, such as sore throats, rashes, and common colds.

• share
• favorite_border

Atlanta Falcons and Atlanta United owner Arthur Blank and Nina Bhardwaj, MD, PhD, will be honored for their contributions to prostate cancer research.

• share
• favorite_border

Rachel L. Miller, MD, FAAAAI, an expert in asthma and allergies, has been appointed as Chief of Clinical Immunology at the Icahn School of Medicine at Mount Sinai.

• share
• favorite_border

The FAIRshake Toolbox Developed to Promote Information Exchange in Biomedicine

• share
• favorite_border

A mother’s exposure to particulate air pollution during pregnancy is associated with reduced cardiac response to stress in six-month-old infants, according to Mount Sinai research published in Environmental Health Perspectives in October. This study is the first to find that particulate air pollution exposure in utero can affect heart rate variability, which is a known risk factor for health issues.

• share
• favorite_border

Study is the first to identify specific cellular toxicity and show improvement after stopping supplement use

• share
• favorite_border

Exposure during the first trimester of pregnancy to mixtures of suspected endocrine-disrupting chemicals found in consumer products is related to lower IQ in children by age 7, according to a study by researchers at the Icahn School of Medicine at Mount Sinai and Karlstad University, Sweden, published in Environment International in October. This study is among the first to look at prenatal suspected endocrine-disrupting chemical mixtures in relation to neurodevelopment.

• share
• favorite_border

Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome

• share
• favorite_border

INCLUDE project aims to address conditions and apply knowledge to larger population

• share
• favorite_border

Most people born prematurely are likely to survive into adulthood without developing major chronic diseases or conditions like asthma, hypertension, diabetes, and other illnesses, Mount Sinai researchers report in a study published today in the Journal of the American Medical Association (JAMA).

• share
• favorite_border

Three world-renowned environmental health researchers from the Institute for Exposomic Research at Mount Sinai have been awarded grants worth a total of $25 million from the National Institutes of Health (NIH) for the newly formed Human Health Environmental Assessment Resource (HHEAR). This program is dedicated to measuring all the environmental factors faced in people’s lives—a new science called “exposomics,” which is expected to yield important insights about disease processes and potential treatments.

• share
• favorite_border

The Icahn School of Medicine at Mount Sinai – an international leader in medical and scientific training, biomedical research, and patient care – today announced the launch of a new Diversity and Inclusion Hub, a groundbreaking initiative spearheaded by the Mount Sinai’s Office of Diversity and Inclusion.

• share
• favorite_border

A team led by researchers at the Icahn School of Medicine at Mount Sinai is getting closer to a universal flu vaccine using a novel approach they’ve developed called chimeric hemagglutinin (cHA).

• share
• favorite_border

Mount Sinai researchers have identified a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who would otherwise have no treatment options, according to a study published in October in Cancer Cell.

• share
• favorite_border

Study based at the Icahn School of Medicine at Mount Sinai and other centers finds new system has safety, efficacy benefits for people with type 1 diabetes

• share
• favorite_border

Affects Brain Region Connected to Pancreas

• share
• favorite_border

Study results illuminate the potential of novel approach for the treatment of chronic pain.

• share
• favorite_border

May also help predict therapeutic responses

• share
• favorite_border

Findings could lead to better understanding of ischemic cardiovascular events and help the development of new treatments

• share
• favorite_border

A study published online on Friday, October 4, in The American Journal of Psychiatry found that deep brain stimulation (DBS) of an area in the brain called the subcallosal cingulate (SCC) provides a robust antidepressant effect that is sustained over a long period of time in patients with treatment-resistant depression—the most severely depressed patients who have not responded to other treatments

• share
• favorite_border

-Specialized training at Settlement Health in East Harlem prepares physicians to care for patients from infancy to adulthood, including their families -Efforts represent Mount Sinai’s commitment to marginalized communities and efforts to reduce health care inequities

• share
• favorite_border

Mount Sinai researchers have discovered how the enzyme DNA polymerase delta works to duplicate the genome that cells hand down from one generation to the next.

• share
• favorite_border

Mount Sinai Health System has earned the 2019 College of Healthcare Information Management Executives (CHIME) Most Wired recognition according to survey results released this month.

• share
• favorite_border

Findings reveal how auditory hallucinations may arise in patients with schizophrenia and provide potential new targets for early detection and treatment

• share
• favorite_border

Research identifies a new target for helping patients decrease risk of heart disease and promote health

• share
• favorite_border

The Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai has begun offering a Master of Health Administration (MHA) degree. Applications for the new MHA program are now open for enrollment starting in January, March, or September, 2020.

• share
• favorite_border

Mount Sinai neuroscientist shines light on how the brain optimizes capacity to store memories across a lifetime

• share
• favorite_border

Eighth annual SINAInnovations festival on October 15-16 at Icahn School of Medicine at Mount Sinai in New York City

• share
• favorite_border

NIH contract award of up to $132 million will further ongoing efforts to develop a long-lasting vaccine

• share
• favorite_border

Results from international clinical trial ‘TWILIGHT’ could change standard of care for high-risk cases

• share
• favorite_border

Long Island Flagship Hospital of the Mount Sinai Health System

• share
• favorite_border

Mount Sinai researchers have identified elemental signatures in baby teeth that are unique to attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, and cases when both neurodevelopment conditions are present, which suggests that the metabolic regulation of nutrients and toxins play a role in these diseases, according to a study published in Translational Psychiatry in September.

• share
• favorite_border

In the first clinical trial to evaluate two biologic therapies for moderate to severe ulcerative colitis (UC) head to head, Mount Sinai researchers found vedolizumab to be superior to adalimumab in a variety of measures. In a separate study, the investigators reported that ustekinumab is more effective than placebo as an induction and maintenance therapy for UC. The studies were published today in the The New England Journal of Medicine.

• share
• favorite_border

Three Mount Sinai Health System hospitals have received renewed national recognition for excellence in nursing from the American Nurses Credentialing Center's (ANCC) Magnet Recognition Program®. The Mount Sinai Hospital received Magnet® designation for the fourth consecutive time; Mount Sinai Queens—the Queens campus of The Mount Sinai Hospital—received its second designation; and New York Eye and Ear Infirmary of Mount Sinai (NYEE) received its third Magnet® designation.